Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Administration Efficacy/effectiveness Safety Newborn (0-1 years) Hepatitis B Diphtheria Pertussis Tetanus Haemophilus influenzae type B Poliomyelitis
Efficacy/effectiveness Safety Administration All age groups Haemophilus influenzae type B
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Efficacy/effectiveness Safety Adults (18+) Elderly (65+) Haemophilus influenzae type B
Economic aspects All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Hepatitis B Varicella
Economic aspects All age groups Germany Mumps Measles Pertussis Varicella
Efficacy/effectiveness Safety All age groups Influenza Haemophilus influenzae type B
Administration Efficacy/effectiveness Newborn (0-1 years) Haemophilus influenzae type B Meningococcal disease Pneumococcal disease
Varicella